Evaluating a new approach to improve HIV testing and treatment in Alabama

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to implement and assess a combination intervention designed to enhance HIV testing, linkage to care, and viral suppression in Mobile County, Alabama. The intervention includes community-based HIV testing in high-need areas, expedited linkage to care through Project Connect, and a Rapid ART Start program. The study will utilize a data-driven approach and involve in-depth interviews and observations to adapt the intervention to local workflows. The effectiveness of the intervention will be evaluated through clinical outcomes, such as days to viral suppression, and implementation outcomes, such as the proportion of the population tested for HIV.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* AIM 1 \& 3:
* Fit into one of the following categories:

  1\) MCHD leadership, 2) ADPH leadership, 3) clinic administrators, 4) outreach testing specialists, 5) linkage coordinators and community health workers, 6) physicians, 7) nurses, 8) counselors all working at HIV care facilities in the six MCHD jurisdiction counties.
* Over the age of 18 years old.

AIM 2: (IDIs)

* Over the age of 13 years old
* Tested for HIV in MCHD jurisdiction from time of COASTAL implementation to 36 months post-implementation start date.

Exclusion Criteria:

* Exclusion criteria include unwillingness or inability to provide informed consent.

Where it's running

• University of Alabama at Birmingham
  Birmingham, Alabama, United States Recruiting

Study contacts

• Study coordinator: Mariel Parman
• Email: marielparman@uabmc.edu
• Phone: 205-996-6337

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using B-OK Bottles to boost HIV and ART literacy in South Africa

  This study tests whether low-cost B-OK bottles help adults in Gauteng understand HIV, ART, and U=U better, compared with standard information or a short video.

  Recruiting University of Pennsylvania · Johannesburg, Gauteng · NCT07703891

• Project SHIELD 2.0: Police Education to Support Public Health in Kentucky

  Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Lexington, Kentucky · NCT07804121

• New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV

  This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.

  Recruiting Indiana University · Lilongwe · NCT07793006

• Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV

  This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.

  Recruiting Fenway Community Health · Boston, Massachusetts · NCT07762066

• HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters

  This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.

  Recruiting at 2 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · San Francisco, California and 7 other locations · NCT07757802

• Stigma-reducing program to help women who use drugs stay in HIV care

  This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.

  Recruiting Johns Hopkins Bloomberg School of Public Health · Kyiv, Kyiv Oblast · NCT07751978

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.